Product Information
LACOSAMIDE 200 MG/20 ML CUP is a generic product labeled by PAI Holdings LLC, priced at $0.0829 per ML under NDC 00121404895. Its NADAC has been published 155 times since Oct 18, 2023.
FDA first approved this application on Aug 26, 2022. Its Orange Book therapeutic-equivalence code is AA.
The Low Outlier badge above means this manufacturer's average price in the Lacosamide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/20mL
Manufacturer
PAI Holdings LLCNDC
00121404895
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216151FDA Approved
8/26/2022
TE Code
AA
On Market Since
8/26/2022
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 200 MG/20 ML CUP has been published 155 times since Oct 18, 2023, and over the history we have for it it has declined 30.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0829 per ML |
|---|---|
| All-time high | $0.1475 (Apr 10, 2024) |
| All-time low | $0.0820 (Aug 19, 2026) |
| 52-week high | $0.1070 |
| 52-week low | $0.0820 |
| Median price | $0.1071 |
| Average price | $0.1105 |
| Largest weekly change | +32.8% (Jun 19, 2024) |
| Weeks tracked | 155 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lacosamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lacosamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LACOSAMIDE 200 MG/20 ML CUP?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 200 MG/20 ML CUP, manufactured by PAI Holdings LLC, is $0.0829 per ML (NDC 00121404895), effective Sep 30, 2026.
How has the price of LACOSAMIDE 200 MG/20 ML CUP changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 200 MG/20 ML CUP has declined 30.5%. It has been tracked across 155 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 200 MG/20 ML CUP?
Since Oct 18, 2023, the NADAC for LACOSAMIDE 200 MG/20 ML CUP has ranged from a low of $0.0820 (Aug 19, 2026) to a high of $0.1475 (Apr 10, 2024), with a median of $0.1071 per ML.
Are there cheaper alternatives to LACOSAMIDE 200 MG/20 ML CUP?
No other NADAC-published product currently shares the active ingredient and strength of LACOSAMIDE 200 MG/20 ML CUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LACOSAMIDE 200 MG/20 ML CUP?
LACOSAMIDE 200 MG/20 ML CUP (NDC 00121404895) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.